The latest worry on the rise is 'Ozempic scalp,' aka hair loss and a painful scalp ... Tyla has reached out to Novo Nordisk ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk ...

With negotiations on the first batch of 10 medicines now complete, the response from some in industry appears to be one of ...

These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest for ...

CEO Ian Read and former CFO Frank D’Amelio said on Wednesday evening that they will step back from activist investor ...

A little over a year ago, I took the stage at Livewire Live and made a 'shocking prediction' for 2024: we would witness “the ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

A little over a year ago, I took the stage at Livewire Live and made a 'shocking prediction' for 2024: we would witness “the ...